SCHEMBL6153777

SCHEMBL6153777

N#Cc1ccc(Nc2ccc([N+](=O)[O-])cc2)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 2/20 0.50
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KIF11 P52732 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
BCL6 P41182 1/20 0.46
BCOR Q6W2J9 1/20 0.46
VCAM1 P19320 2/20 0.45
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
DHODH Q02127 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 2/20 0.42
MMP14 P50281 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PGR P06401 1/20 0.41
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25837938 0.82 VCAM1 (0.59) MEN1KMT2AVCAM1ALDH1A1LMNA
SCHEMBL361867 0.82 VCAM1 (0.59) MEN1KMT2AVCAM1ALDH1A1LMNA
Fluoride SCHEMBL28618487 0.81 VCAM1 (0.57) MEN1KMT2ABCL6BCORVCAM1
SCHEMBL11591052 0.77 MAPT (0.40) KIF11MEN1KMT2ABCL6BCOR
SCHEMBL4957626 0.75 HPGD (0.83) ALOX12HPGDL3MBTL1KIF11MEN1
SCHEMBL18289622 0.75 HPGD (0.83) ALOX12HPGDL3MBTL1KIF11MEN1
SCHEMBL18289621 0.75 HPGD (0.83) ALOX12HPGDL3MBTL1KIF11MEN1
SCHEMBL395942 0.75 HPGD (0.83) ALOX12HPGDL3MBTL1KIF11MEN1
SCHEMBL13384748 0.74 BCL6 (0.47) ALOX12HPGDL3MBTL1MEN1KMT2A
SCHEMBL15954408 0.74 MAPT (0.53) HPGDL3MBTL1MEN1KMT2ABCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 ALOX12 2306/4885HPGD 339/4885L3MBTL1 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.